Latest S-1 registration statements

SCWorx Corp. filed an S-1 registration statement for the resale of up to 53.2 million common shares by selling stockholders, while grappling with recurring losses, negative cash flow, and a Nasdaq delisting threat.

GenFlat Holdings, an early-stage collapsible marine container company, is seeking to raise approximately $15 million through a public offering to fund operations and repay short-term loans.

Crescent Biopharma announces strategic partnerships with Kelun-Biotech and Paragon Therapeutics, securing $100 million in upfront payments and advancing its oncology pipeline with CR-001, CR-002, and SKB105 (CR-003) towards Phase 1/2 trials in 2026.

Aethlon Medical, Inc. filed an S-1 registration statement for the resale of up to 2,031,024 shares of common stock underlying various warrants, primarily from a December 2025 private placement.

Charging Robotics Inc. filed an S-1/A amendment detailing its proposed resale of common stock, the acquisition of Revoltz Ltd., and its application to list on the Nasdaq Capital Market.

CirTran Corporation filed an S-1 registration statement for the resale of up to 1,731,509 shares of common stock by a selling stockholder, potentially raising up to $10 million for working capital and debt repayment.

Buda Juice, a pioneer in the UltraFresh™ juice category, is launching its initial public offering to raise capital for national expansion and strengthen its cold-chain distribution network.

Twenty One Capital, Inc. files S-1 to register the resale of $486.5 million in 1.00% convertible senior notes due 2030 and up to 35,068,912 shares of Class A common stock underlying these notes.

MetaVia Inc. announced a public offering of up to 1.57 million units to fund its clinical programs, following positive top-line data from its Phase 1 trial for obesity and Phase 2a trial for MASH.

Jefferson Capital, Inc. details significant revenue and net income growth, strategic acquisitions, and a planned share repurchase in its latest S-1 filing.

Signing Day Sports, Inc. announces an underwritten public offering of common stock and warrants, alongside a proposed business combination with BlockchAIn Digital Infrastructure, Inc., despite ongoing financial losses and going concern doubts.

cbdMD, Inc. has entered into a $20 million equity line of credit agreement with C/M Capital Master Fund, LP to bolster working capital and general corporate purposes, while navigating significant dilution risks.

Bimergen Energy Corporation, a development-stage renewable energy company, is offering 1.26 million shares and warrants to raise $10.6 million for BESS project development and working capital, while pursuing a NYSE American listing.

Celularity Inc. filed an S-1 registration statement for the resale of up to 14,078,938 Class A Common Stock by selling stockholders, while facing substantial doubt about its ability to continue as a going concern.

USBC, Inc. files an amended S-1 registration statement for the resale of 367.6 million common shares by selling stockholders, including Goldeneye 1995 LLC, without receiving any proceeds.

Edgemode, Inc. is shifting its focus to AI data center development in Spain, securing a $50 million equity line of credit, but faces significant financial challenges, a going concern warning, and a major legal dispute.

Aspira Women's Health Inc. filed an S-1 registration statement for the resale of up to 16.7 million common shares by Lincoln Park Capital Fund, LLC, securing up to $10.0 million in committed equity financing.

Mitesco, Inc. files an S-1 registration for the resale of over 106 million common shares, highlighting a strategic pivot to data center and AI services following the closure of its unprofitable clinic operations, amidst significant debt restructuring and ongoing going concern doubts.

FreeCast, Inc. filed an S-1/A amendment for a direct listing on the Nasdaq Capital Market, registering 19.78 million Class A common shares for resale, while facing significant accumulated deficits and a going concern warning.

Smart Powerr Corp. filed an S-1 registration statement for the resale of 16.36 million common shares by selling stockholders, representing 78.6% of outstanding stock, with no proceeds to the company.

First Choice Healthcare Solutions, Inc. (FCHS) is undertaking a strategic pivot from its legacy orthopedic business to a national chain of primary care and wellness clinics, supported by a new public offering of Series D Convertible Preferred Stock and Warrants.

Encore Medical, a structural heart device company, is launching an IPO to raise $12.96 million for critical US clinical trials for stroke and migraine indications, despite a history of net losses and going concern doubts.

AMC Robotics Corporation has filed an S-1 registration statement for the resale of over 21 million shares following its business combination with AlphaVest Acquisition Corp, detailing its smart security product business, financial performance, and future growth plans.

Propanc Biopharma, a development-stage oncology company, reported substantial net losses and negative cash flows, raising significant doubt about its ability to continue as a going concern, despite recent capital raises.

International Battery Metals Ltd. filed an S-1/A registration statement to allow selling shareholders to resell up to 93.48 million common shares and 39.22 million warrants, with the company not receiving proceeds from share sales but potentially from warrant exercises.

Safe & Green Holdings Corp. filed an S-1 registration statement for the resale of up to 8,714,285 shares of common stock underlying Series C Convertible Preferred Stock by a selling stockholder.

VSee Health is registering over 33.8 million shares for resale by selling stockholders, while its auditors express substantial doubt about the company's ability to continue as a going concern.

QT Imaging Holdings, Inc. filed an S-1/A registration statement detailing recent private placements, debt restructuring, and its strategy for commercializing breast imaging technology.

Laser Photonics Corporation filed an S-1/A to register up to 3,871,964 shares of common stock for resale by selling stockholders, following several recent financing and acquisition activities.

Cadrenal Therapeutics filed an S-1 registration statement for the resale of 428,227 common shares underlying warrants from a recent private placement and registered direct offering.